Sunshine Pharma (06887): Equity Transfer Among Controlling Shareholder Group Members

Stock News
2025/12/29

The Board of Directors of the Company has been informed by Mr. Zhang Yushuai and Ms. Guo Meilan, each a member of the Company's controlling shareholder group, that, in light of Ms. Guo's decision to retire and reduce her involvement in the Group's business, on December 29, 2025, Mr. Zhang and Ms. Guo entered into an equity transfer agreement.

Pursuant to the agreement, Ms. Guo transferred her 71.75% equity interest in Ruyuan Yao Autonomous County Yuneng Electronic Industrial Co., Ltd. and her 74.63% equity interest in Ruyuan Yao Autonomous County Xinjing Technology Development Co., Ltd. to Mr. Zhang.

The nominal consideration for each transfer was RMB 1.00. Ms. Guo is the mother of Mr. Zhang.

Following the completion of the relevant regulatory filings and the settlement of the equity transfers, Mr. Zhang will hold 99.2% and 75.0% equity interests in Ruyuan Yuneng Electronic and Ruyuan Xinjing Technology, respectively.

Consequently, Mr. Zhang will become the new leader of the controlling shareholder group, while Ms. Guo will cease to be a member of the group.

The Board of Directors is of the opinion that the equity transfer will not have any adverse impact on the overall financial and operational conditions of the Company.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10